Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

Study Summary

The objective of this study is to determine safety and efficacy of silodosin, which is a treatment for benign prostatic hyperplasia with high selectivity to α1A-receptor, on patients with benign prostatic hyperplasia accompanied by nocturia.